Our mission is to create quality biologics with a passion to improve the lives of patients. Polpharma Biologics is an international biotechnology company with integrated operations in the European Union (EU), developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production preparing drugs for future commercial partnerships with global pharmaceutical players. The company’s expertise is in the development and manufacturing of medicines based on microbial and mammalian expression systems. With its cell line development center in Netherlands and two centers of development and manufacturing in Poland, Polpharma Biologics creates growth and development opportunities for biotechnology specialists. Find out more at our website
View Top Employees from Polpharma BiologicsWebsite | https://www.polpharmabiologics.com/ |
Revenue | $18 million |
Employees | 1,076 (712 on RocketReach) |
Address | ulica Trzy Lipy 3, PL, Gdańsk, Pomorskie 80-172, PL |
Phone | +48 58 770 95 59 |
Industry | Biotechnology Research, Business Services General, Pharmaceutical, Business Services, Health Care |
Keywords | Biologics, Biosimilars, Therapeutic Activities |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Polpharma Biologics employee's phone or email?
The Polpharma Biologics annual revenue was $18 million in 2024.
Piotr Korycki is the President of the Management Board, Managing Director of Polpharma Biologics.
712 people are employed at Polpharma Biologics.
Polpharma Biologics is based in Gdańsk, Pomorskie.
The NAICS codes for Polpharma Biologics are [3254, 325, 32541, 32].
The SIC codes for Polpharma Biologics are [283, 28].